| Name | Title | Contact Details |
|---|
At Health IQ, we believe the best way to improve the health of the world is to celebrate the health conscious rather than harassing those who are not.
NorthStar Clinical Communications is a Washington Crossing, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
The Home Instead Senior Care® network is the world`s leading provider of personalized in-home care services. We have over 1,100 independently owned and operated franchise offices worldwide that employ compassionate CAREGivers who share our dedication to enhancing the lives of aging adults and their families. Services span the care continuum, from companionship and personal care to specialized Alzheimer`s care and hospice support. Caring for others is part of our DNA, and that includes caring for your career. The Home Instead Senior Care network provides best-in-class training, education, and opportunities for career advancement. It also offers you the opportunity to be part of a supportive family-like culture where you`re encouraged to talk with your local office for support, share stories, and seek guidance.
Trustmark, through its operating divisions and subsidiaries, offers specialized expertise in voluntary benefits, self-funded health plan design and administration, and the delivery of wellness, fitness, recreation, and injury prevention and treatment programs. Trustmark offers employers of all sizes access to benefit options usually reserved for large companies, combined with the personal service you`d expect from a small firm. Our commitment to building long-term, trusted relationships helps people and businesses thrive. Trustmark: benefits beyond benefits.
Stilla Technologies is a leading global biotechnology company that focuses on accelerating development of next-generation genetic testing by providing researchers and clinicians with a flexible Digital PCR solution for high-resolution genetic analysis and assay development. Stilla`s next-generation Multiplex Crystal Digital PCR™ technology employs cutting-edge microfluidic innovations and integrates the entire dPCR process on a single chip. The naica® system is highly sensitive, fast, and features an easy workflow, higher levels of multiplexing, and intuitive software. Stilla developed the world`s first 6-color Digital PCR Platform, providing High Multiplexing and Sensitivity for Advancing Cancer & Liquid Biopsy Studies, Cell & Gene Therapies, Infectious Disease & COVID-19 Research, and Wastewater and Environmental Testing and many more applications. Stilla aims to make Digital PCR a lab commodity in all life sciences areas including research, therapeutics, and the omics.